StockTipsArenaBeta

BUY Biocon Ltd — Chandan Taparia, Motilal Oswal

BUYBiocon Ltd
Biocon share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))19 May 2026via Business Today

Entry₹428.15Inferred
Target₹440
Total upside +2.77% (call closed)
Stop lossNot given
Exit₹44026 May 2026, 12:00 pm
Target hit+2.77%0.00%upside left
Follow Chandan Taparia for new calls(30% target hit, 259 closed calls)Get alertsWatch BIOCON for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 10:48 pm IST
5 supporting3 neutral0 opposing
Supports the BUY call (5)

3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·20 May · 6d ago

Outcome of Board Meeting regarding Change in Long Term Incentive Plan.

BSE · Company Update·7 May · 3w ago

(opens in new tab)

Outcome of Board Meeting regarding acquisition of equity shares of BBL.

BSE · Company Update·7 May · 3w ago

(opens in new tab)

Biocon reported Q4FY26 total income of Rs 4,569 Cr, EBITDA at Rs 1,073 Cr, and Net Profit (before exceptional items) at Rs 179 Cr. FY26 figures were Rs 17,270 Cr, Rs 3,798 Cr, and Rs 436 Cr respective

NSE · Press Release·7 May · 3w ago

(opens in new tab)

Outcome of Board Meeting held on May 07, 2026 regarding Acquisition.

NSE · Outcome of Board Meeting·7 May · 3w ago

(opens in new tab)
Neutral / worth noting (3)

Biocon Limited's Board of Directors approved audited financial results for the quarter and year ended March 31, 2026, recommended a final dividend of 10% (Re. 0.50 per share), and recommended the appo

NSE · Outcome of Board Meeting·7 May · 3w ago

(opens in new tab)

Biocon Limited's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, and recommended a final dividend of 10% (Re. 0.50 per share). The Board also r

NSE · Outcome of Board Meeting·7 May · 3w ago

(opens in new tab)

Biocon Limited announced its audited financial results for the quarter and year ended March 31, 2026. The company also recommended a final dividend of 10% (Re. 0.50 per equity share).

NSE · Outcome of Board Meeting·7 May · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Biocon

All analyst calls on Biocon

More from Chandan Taparia, Motilal Oswal

Every call and its outcome